7andcounting
03-07-2012, 12:18 PM
I spoke with Genentech today and they said 60 sites out of the 177 have now been opened. These sites are not all updated on the clinical trials gov site. There is a link below to this study, and if you want to know if there is a site open near you, call Genentech:888-662-6728 (U.S. Only) 888-662-6728 (U.S. Only)genentechclinicaltrials@druginfo.com (genentechclinicaltrials%40druginfo.com?subject=NC T01419197, TDM4997g, A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Patients With HER2-Positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-Directed Therapy)
A study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Patients With HER2-Positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-Directed Therapy
This study is currently recruiting participants.
Verified February 2012 by Genentech
First Received on August 16, 2011. Last Updated on February 21, 2012 History of Changes (http://clinicaltrials.gov/ct2/archive/NCT01419197)
Link to this study:
http://clinicaltrials.gov/ct2/show/study/NCT01419197?term=T-DM1&rank=10&show_locs=Y#locn
A study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Patients With HER2-Positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-Directed Therapy
This study is currently recruiting participants.
Verified February 2012 by Genentech
First Received on August 16, 2011. Last Updated on February 21, 2012 History of Changes (http://clinicaltrials.gov/ct2/archive/NCT01419197)
Link to this study:
http://clinicaltrials.gov/ct2/show/study/NCT01419197?term=T-DM1&rank=10&show_locs=Y#locn